Trimethoprim and Sulfamethoxazole are Selective Inhibitors of CYP2C8 and CYP2C9, Respectively

Wen, Xia, Wang, Jun-Sheng, Backman, Janne T., Laitila, Jouko, Neuvonen, Pertti J.·2002·Drug Metabolism and Disposition
DOI 10.1124/dmd.30.6.631

Cited by (174)

Items 101–174 of 174

  1. Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya
    Michael Green, Kephas Otieno, Abraham Katana, Laurence Slutsker, Simon Kariuki, Peter Ouma, Raquel González, Clara Menéndez, Feiko O. ter Kuile, Meghna R. Desai · 2016 · Malaria Journal
  2. Trimethoprim–sulphamethoxazole does not affect the pharmacokinetics of sirolimus in renal transplant recipients
    Ylva Böttiger, C Brattström, Lars Bäckman, Kerstin Claesson, James T. Burke · 2005 · British Journal of Clinical Pharmacology
  3. [Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs].
    Luis A. Quiñones, Mario Rosero Pahi, Angela Roco A, Iván Moreno T, Jaime Sasso A, Nelson Varela, Dante Cáceres, Iván Saavedra S · 2008 · PubMed
  4. Evaluation of Drug-drug Interaction Potential of Beraprost Sodium Mediated by P450 In Vitro
    Tominaga Fukazawa, Kanako Yajima, Yohei Miyamoto · 2008 · YAKUGAKU ZASSHI
  5. Papel de las enzimas citocromo p450 en el metabolismo de fármacos antineoplásicos: Situación actual y perspectivas terapéuticas
    Luis A. Quiñones, Mario Rosero Pahi, Ángela Roco A, Iván Moreno T, Jaime Sasso A, Nelson Varela, Dante Cáceres, Iván Saavedra S · 2008 · Revista médica de Chile
  6. Unusual hypersensitivity to warfarin in a critically ill patient
    Hiroki Konishi, Yawara Eguchi, Mika Fujii, Takao Saotome, Takeshi Sasaki, Kenichiro Takahashi, Masatomo Sudo, Hiroaki Morii, Tokuzo Minouchi, Akihiro Yamaji · 2004 · Journal of Clinical Pharmacy and Therapeutics
  7. Determination of trimethoprim in low-volume human plasma by liquid chromatography
    Matthew W. Hruska, Reginald F. Frye · 2004 · Journal of Chromatography B
  8. Metabolism of bupropion by baboon hepatic and placental microsomes
    Xiaoming Wang, Doaa Reda Abdelrahman, Valentina M. Fokina, Gary D.V. Hankins, Mahmoud S. Ahmed, Tatiana N. Nanovskaya · 2011 · Biochemical Pharmacology
  9. Drug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature review
    Nada Božina, Lana Ganoci, Livija Šimičević, Katarina Gvozdanović, Iva Klarica Domjanović, Margareta Fištrek Prlić, Tena Križ, A Ana Borić-Bilušić, Mario Laganović, Tamara Božina · 2021 · Archives of Industrial Hygiene and Toxicology
  10. Towards Safer and More Predictable Drug Treatment – Reflections from Studies of the First BCPT Prize Awardee
    Pertti J. Neuvonen · 2012 · Basic & Clinical Pharmacology & Toxicology
  11. Extended release tacrolimus and antiretroviral therapy in a renal transplant recipient: so extended!
    Johann Morelle, Eric Jean Goffin, Pierre E. Wallemacq, Martine De Meyer, Jean Cyr Yombi, Michel Mourad, Nada Kanaan · 2010 · Transplant International
  12. Computational Analysis of Single Nucleotide Polymorphisms Associated with Altered Drug Responsiveness in Type 2 Diabetes
    Valerio Costa, Antonio Federico, Carla Pollastro, Carmela Ziviello, Simona Cataldi, Pietro Formisano, Alfredo Ciccodicola · 2016 · International Journal of Molecular Sciences
  13. Metabolism and interactions of pesticides in human and animal in vitro hepatic models
    Khaled M. Abass · 2010
  14. Sulfamethoxazole: Molecular docking and crystal structure prediction
    David Stephen Arputharaj, R. Meenashi, Mehboobali Pannipara, Abdullah Godran Al-Sehemi, Mohamed Mustafa Abdul rahman · 2022 · Results in Chemistry
  15. Bactericidal and Bacteriostatic Antibiotics
    Sachin M. Patil, Parag Patel · 2021 · IntechOpen eBooks
  16. Anti-tumor activity of trimethoprim-sulfamethoxazole against melanoma skin cancer through triggering allergic reaction and promoting immunity
    Hee‐Yun Kim, Ho‐Geun Kang, Hyung‐Min Kim, Hyun‐Ja Jeong · 2023 · International Immunopharmacology
  17. Interaction of vitamin K antagonists and trimethoprim-sulfamethoxazole: ignore at your patient’s risk
    Sarah Fetterman Hale, Timothy S. Lesar · 2013 · Drug metabolism and drug interactions
  18. Cotrimoxazole-Induced Hypoglycaemia in a Patient with Churg-Strauss Syndrome
    Russell Senanayake, Mamoun Mukhtar · 2013 · Case Reports in Endocrinology
  19. Recurrent erythematous plaques on sun-exposed sites in an African American boy with chronic granulomatous disease
    Mamina M. Turegano, Chyi‐Chia Richard Lee, Harry L. Malech, Suk See De Ravin, Edward W. Cowen, Isaac Brownell · 2014 · Journal of the American Academy of Dermatology
  20. Variability in Cytochrome P450-Mediated Metabolism of Cardiovascular Drugs: Clinical Implications and Practical Attempts to Avoid Potential Problems
    Espen Molden · 2004 · Heart Drug
  21. CYP2C8-Mediated Drug–Drug Interactions and the Factors Influencing the Interaction Magnitude
    Lingling Zhu, Lingyan Yu, Yanhong Wang, Quan Zhou · 2025 · Drug Design Development and Therapy
  22. Pharmacokinetic Drug-drug Interaction of Antibiotics Used in Sepsis Care in China
    Xuan Yu, Zixuan Chu, Jian Li, Rong‐Rong He, Yaya Wang, Chen Cheng · 2020 · Current Drug Metabolism
  23. Resistance to Antimalarial Drugs: Parasite and Host Genetic Factors
    Rajeev K. Mehlotra, Peter A. Zimmerman · 2006 · Springer eBooks
  24. Drug Interactions
    Markus Alexander Zeitlinger · 2016 · Springer eBooks
  25. Rhabdomyolysis due to Trimethoprim-Sulfamethoxazole Administration following a Hematopoietic Stem Cell Transplant
    Alexander Augustyn, Mona Lisa Alattar, Harris V K Naina · 2015 · Case Reports in Oncological Medicine
  26. Discrepancies between medication records of anticoagulation clinics and pharmacy records
    Tom Schalekamp, Carolien Smit, Johanna H. H. van Geest‐Daalderop, Hanneke de Vries‐Goldschmeding, Anthonius de Boer · 2006 · Pharmacoepidemiology and Drug Safety
  27. Antibacterial Agents, Sulfonamides
    Michele A. Weidner‐Wells, Mark J. Macielag · 2003 · Wiley eBooks
  28. Cytochrome P450 enzymes— in vitro , in vivo , and in silico studies
    Miia Turpeinen · 2006
  29. Construction of a fused grid-based CYP2C8-Template system and the application
    Yasushi Yamazoe, Yoshiya Yamamura, Kouichi Yoshinari · 2023 · Drug Metabolism and Pharmacokinetics
  30. Cotrimoxazole-induced hypoglycemia in outpatient setting
    Ahad Eshraghian, Gholamhossein Ranjbar Omrani · 2014 · Nutrition
  31. Sulfonamides and Trimethoprim
    STEPHEN H. ZINNER, Kenneth Hugh Mayer · 2010 · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
  32. A factorial-design/assisted HPLC method for simultaneous monitoring of phenytoin, trimethoprim, and sulphamethoxazole in plasma samples to optimize therapy and mitigate toxicity risks
    Mona E. El Sharkasy, Rasha Aboshabana, Manar M. Tolba, Mohamed Ibrahim Walash, Fathalla F. Belal · 2024 · Microchemical Journal
  33. Antibacterial Distribution and Drug–Drug Interactions in Cancer Patients
    Ursula Theuretzbacher, Markus Alexander Zeitlinger · 2011 · Humana Press eBooks
  34. Toward reduction in animal sacrifice for drugs: Molecular modeling ofMacaca fascicularisP450 2C20 for virtual screening ofHomo sapiensP450 2C8 substrates
    Francesco Rua, Giovanna Di Nardo, Sheila J. Sadeghi, Gianfranco Gilardi · 2012 · Biotechnology and Applied Biochemistry
  35. Identification of Therapeutic Drug Target of Stenotrophomonas maltophilia Through Subtractive Genomic Approach and in-silico Screening Based on 2D Similarity Filtration and Molecular Dynamic Simulation
    Rahul Chandela, Dhananjay Jade, Surender Mohan, Ridhi Sharma, Shobana Sugumar · 2020 · Combinatorial Chemistry & High Throughput Screening
  36. EFFECTS OF CO-TRIMOXAZOLE CO-ADMINISTRATION ON THE PHARMACOKINETICS OF AMODIAQUINE IN HEALTHY VOLUNTEERS
    Adebusuyi Akande Ademisoye, Soyinka Julius Olugbenga, Jonathan Adebanjo Adegbola, Abdullahi Sa’ad Toyin, Cyprian O. Onyeji · 2015 · International Journal of Pharmacy and Pharmaceutical Sciences
  37. Coma hypoglycémique et co-trimoxazole chez un patient non diabétique
    P.L. Conan, France Charton, A. Quiblier, J. Margery, F. Rivière · 2016 · Médecine et Maladies Infectieuses
  38. Is this reaction caused by this drug?
    Willem L. Diemont · 2005 · PubMed
  39. Concomitant Use of Cotrimoxazole and Atazanavir in HIV-infected Patients: A Therapeutic Drug Monitoring and Pharmacovigilance Based Dual Approach
    Joe Miantezila Basilua, Roland Landman, Laurent Chouchana, Minh Lê, Olivier Sawoo, Gaston Tona Lutete, Bruno Eto, Gilles Peytavin, Philippe Pochart · 2019 · Current Clinical Pharmacology
  40. Optimizing the dosing regimen of roxadustat in kidney transplant recipients with early post-transplant anemia
    Zhuowei Shen, Xiu-Yan Yang, Lu Han, Xi Yang, Jiao Xie, Xiaoqin Liu, Juehui Mao, Hao‐Ran Dai, Wei-Wei Kong, Xiaoying Wu et al. · 2024 · Journal of Pharmaceutical Sciences
  41. Drug interactions medicine
    Markus Alexander Zeitlinger · 2010 · Springer eBooks
  42. Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Common Problem Drugs and How to Prescribe Them
    Vera S. Donnenberg, Philip Chaikin, Maja Mandić, Bernd Meibohm, John van den Anker, Erin Rhinehart, Anne N. Nafziger, James F. Burris · 2019 · The Journal of Clinical Pharmacology
  43. New tariquidar-like ABCB1 modulators in cancer chemotherapy:Preclinical pharmacokinetic, pharmacodynamic investigations and computational studies
    Peter Höcherl · 2010
  44. Cytochrome P450-mediated drug interactions affecting lidocaine
    Mika H. Isohanni · 2009 · Työväentutkimus Vuosikirja
  45. Effects of Cytochrome P450 Enzyme Inhibitors on the Pharmacokinetics of Nonsteroidal Anti-inflammatory Drugs and Venlafaxine
    Ville-Veikko Hynninen · 2008 · UTUPub (University of Turku)
  46. N-Acetyltransferase (NAT) 1 and NAT2 Enzyme Activities Drive Interindividual Variability in Sulfamethoxazole N-Acetylation
    Lanphier, Raeanne M., Latham, Bethany D., Gerringer, Amanda J., Interrante, Tyler, Jones, Corbin D., De Buysscher, Tristan, Fallon, John K., Jackson, Klarissa D. · 2025 · Drug Metabolism and Disposition
  47. Pharmacokinetic interaction of enrofloxacin/trimethoprim combination following single-dose intraperitoneal and oral administration in rats
    Myeongjin Choi, Sileshi Belew Yohannes, Seung‐Jin Lee, Dereje Damte, Jong-Choon Kim, Joo‐Won Suh, Seung‐Chun Park · 2013 · European Journal of Drug Metabolism and Pharmacokinetics
  48. Higher Atazanavir Plasma Exposure in Rats is Associated with Gut Microbiota Changes Induced by Cotrimoxazole
    Joe Miantezila Basilua, Olivier Sawoo, Iréne Mangin, Flore Dossou-Yovo, Aline Boussard, Lucie Chevillard, Gaston Tona Lutete, Bruno Eto, Gilles Peytavin, Philippe Pochart · 2019 · Current Drug Metabolism
  49. Pharmacokinetic interactions of pioglitazone
    Tiina Jaakkola · 2007 · Työväentutkimus Vuosikirja
  50. Integrated Analytical Strategies for Drug Discovery
    Jon S. B. de Vlieger · 2011 · Data Archiving and Networked Services (DANS)
  51. Interaktionen kardialer und antiretroviraler Medikation
    Sabin S Egger, Jürgen Drewe · 2005 · Herz
  52. Massively multiplexed microfluidics maps combinatorial and sequential antibiotic responses in 3D
    Yoon Jeong, Gabriel Mercado-Vasquez, Abinash Padhi, Yiyu Deng, Madhumitha Prakash, Jonathan M. Matthews, Sefika Ozcan, Erdal Toprak, Savaş Tay · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  53. Pharmacokinetic interactions of clozapine in hospitalized patients
    Kari Raaska · 2003 · Työväentutkimus Vuosikirja
  54. STUDIES ON CYP2C8-MEDIATED DRUG INTERACTIONS
    Aleksi Tornio · 2008 · Työväentutkimus Vuosikirja
  55. Pharmacokinetic interactions affecting the antidiabetic repaglinide
    Lauri I. Kajosaari · 2006 · Työväentutkimus Vuosikirja
  56. Role of CYP2C8 in the metabolism of montelukast and imatinib : Studies in vitro, in silico and in humans
    Anne M. Filppula · 2014 · Työväentutkimus Vuosikirja
  57. Bioactivation of Drugs by Cytochromes P450 : New Tools and Concepts for the Characterization of Reactive Metabolites of Drugs
    Micaela C. Damsten · 2009 · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
  58. New insights in phytanic acid metabolism and toxicity
    Jasper C. Komen · 2007 · UvA-DARE (University of Amsterdam)
  59. DRUG-DRUG INTERACTIONS - FROM KNOWLEDGE BASE TO CLINICAL IMPACT
    Marine L. Andersson · 2014 · Figshare
  60. Drug-drug interactions between antiretrovirals and fluconazole in HIV-infected patients
    Desire Fouche · 2012 · SUNScholar (Stellenbosch University)
  61. Mechanism-based inhibition of CYP2C8 by gemfibrozil in humans : characterisation of time and dose relationships
    Johanna Honkalammi · 2011 · Työväentutkimus Vuosikirja
  62. In vitro approaches in evaluation and prediction of drug-drug interactions involving the inhibition of cytochrome P450 enzymes
    Wen Xia · 2002 · Työväentutkimus Vuosikirja
  63. Not Sweet At All
    Mayumi Horibe, Michael J. Bishop · 2015 · Springer eBooks
  64. Role of CYP2C8 in the metabolism of montelukast and imatinib
    Anne M. Filppula · 2014
  65. Effects of gemfibrozil and rifampicin on the pharmacokinetics of HMG-CoA reductase inhibitors
    Carl Kyrklund · 2004 · Työväentutkimus Vuosikirja
  66. Pharmacokinetics of montelukast and zafirlukast as affected by CYP inhibitors
    Tiina Karonen · 2012 · Työväentutkimus Vuosikirja
  67. Trimethoprim
    2012
  68. CHARACTERIZATION OF CYTOCHROME P450 2C8 ACTIVITY IN VIVO: PHARMACOGENETIC AND PHARMACOKINETIC STUDIES OF ROSIGLITAZONE METABOLISM
    Matthew W. Hruska · 2005 · D-Scholarship@Pitt (University of Pittsburgh)
  69. Supplementary Materials, Tables 1-9, Figures 1-8 from The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3
    Christopher P. Guise, Maria Rosaria Abbattista, Rachelle S. Singleton, Samuel D. Holford, Joanna Connolly, Gabi U. Dachs, Stephen B. Fox, Robert Pollock, Justin Harvey, Parry Guilford et al. · 2023
  70. Supplementary Materials, Tables 1-9, Figures 1-8 from The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3
    Christopher P. Guise, Maria Rosaria Abbattista, Rachelle S. Singleton, Samuel D. Holford, Joanna Connolly, Gabi U. Dachs, Stephen B. Fox, Robert Pollock, Justin Harvey, Parry Guilford et al. · 2023
  71. Severe Cotrimoxazole-induced Hypoglycemia in a Patient with Pneumocystis jirovecii Pneumonia: A Case Report
    Samantha Sathyakumar, Swarna Deepak Kuragayala, MBBS Hima Bindu Kotamarthy · 2024 · Indian Journal of Critical Care Case Report
  72. A Case of PT-INR Fluctuation Owing to Drug-drug Interaction Caused By the Combination of Warfarin, Rifampicin, and Sulfamethoxazole-trimethoprim
    Namie Kawasaki, Rie Kajimura, Masanori Fujitani, Uichiro Kimura, Masayuki Umano, Yuichi Koizumi · 2025 · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
  73. Drug–Drug Interactions Between Oral Anticoagulants and Calcineurin Inhibitors in Nephrotic Syndrome for Management of Thromboembolism
    Toshinori Hirai, Kan Katayama · 2026 · Biomedicines
  74. BindingDB Entry 50045943: Reevaluation of the microsomal metabolism of montelukast: major contribution by CYP2C8 at clinically relevant concentrations.
    BindingDB · 2016 · UC San Diego